VHCP Management II

Latest statistics and disclosures from VHCP Management II's latest quarterly 13F-HR filing:

Companies in the VHCP Management II portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Avexis 27.68 1.04M 96.73
Biohaven Pharmaceutical Holding 16.81 1.66M 36.55
Ascendis Pharma A S 13.01 1.30M +31% 36.25
Zogenix 8.78 907057 NEW 35.05
Dbv Technologies 6.18 373617 59.86
BioCryst Pharmaceuticals (BCRX) 4.58 3.17M +27% 5.24
Argenx Se 4.00 647015 22.37
Edge Therapeutics 3.79 1.28M -33% 10.73
Obseva Sa 3.15 1.40M +834% 8.14
Myokardia 3.14 265000 NEW 42.85
Ra Pharmaceuticals 3.10 769771 14.60
Anaptysbio Inc Common 1.62 167550 NEW 34.95
Bellerophon Therapeutics 1.31 4.15M NEW 1.14
Akari Therapeutics 0.72 426297 6.14
Lipocine 0.42 386928 3.97
Kalvista Pharmaceuticals 0.41 221651 6.73
Madrigal Pharmaceuticals 0.37 30000 NEW 44.97
ARCA biopharma (ABIO) 0.34 1.08M 1.15
Adverum Biotechnologies 0.28 280000 3.65
Ocera Therapeutics 0.15 477269 -60% 1.14
Axovant Sciences 0.14 76162 -74% 6.88

Past 13F-HR SEC Filings by VHCP Management II

View All Filings